Osaka Minami Medical Center

Recent papers from Osaka Minami Medical Center

1. From Priority Need to Evidence-to-Action: A Structured Narrative Review of Six Purposefully Selected Anti-Infective InnovationsPharmacoepidemiology · 2026
2. Cord blood-derived natural killer cells engineered with a novel, highaffinity chimeric antigen receptor can eliminate acute myeloid leukemia cells with minimal C-type lectin-like molecule-1 expressionHaematologica · 2026
3. Open centrifugal microfluidic chip with selective surface modification for droplet-based single-cell granzyme B activity profilingSensors and Actuators B Chemical · 2026
4. 123I−FP−CIT uptake and behavioral disinhibition in the frontotemporal dementia spectrum: an exploratory DAT−SPECT studyJournal of Neural Transmission · 2026
5. Report-Level Comparator-Definition Sensitivity in FAERS Cardiometabolic Disproportionality Analysis: A Long-Acting Cabotegravir/Rilpivirine HIV Pharmacovigilance Case StudyPharmacoepidemiology · 2026
6. Progression to Dementia in Very Late‐Onset Schizophrenia‐Like Psychosis Stratified by A lzheimer's Disease and L ewy Body Disease Biomarkers: A Retrospective Cohort StudyPsychogeriatrics · 2026
7. Serum Agalactosyl IgG Predicts Hepatocellular Carcinoma and All‐Cause Mortality After SVR in Advanced Chronic Hepatitis CHepatology Research · 2026
8. Administrative data–based assessment of oral antibiotic prescribing for acute upper respiratory tract infections using the WHO AWaRe classification: a single-center retrospective study at a tertiary care outpatient setting in Japan (2020–2024)Japanese Journal of Infectious Diseases · 2026
9. Preoperative predictors of patient-reported outcomes after joint-preserving forefoot surgery for rheumatoid arthritisThe Bone & Joint Journal · 2026
10. Acquired Erythropoietic Protoporphyria Associated With Myelodysplastic Syndrome: A “Two‐Hit” Mechanism Involving 18q21 AbnormalityThe Journal of Dermatology · 2026
11. Achievement of intermediate treatment targets for Still’s disease under tocilizumab treatment: a post-hoc analysis of the phase III trialImmunological Medicine · 2026
12. A randomized phase III study of pembrolizumab versus pembrolizumab with carboplatin plus pemetrexed for locally advanced or metastatic nonsquamous non–small cell lung cancer with PD-L1 TPS ≥ 50%: LAPLACE-50.Journal of Clinical Oncology · 2026
13. Efficacy of Cabozantinib in Patients With Advanced Renal Cell Carcinoma With Bone Metastasis Assessed by Modified MD Anderson Criteria: An Open‐Label Phase 2 StudyInternational Journal of Urology · 2026
14. Robot-Assisted Spleen-Preserving Distal Pancreatectomy for an Epithelial Cyst Arising from an Intrapancreatic Accessory Spleen: A Case ReportSurgical Case Reports · 2026
15. Improvement of hepatic reserve and changes in liver and spleen volume after balloon-occluded retrograde transvenous obliteration.2026
16. Relapses, Comorbidities, and Predictors of Outcome in Anti‐ GABA A Receptor EncephalitisAnnals of Neurology · 2026
17. BRTO: Past, Present, and Future DirectionsInterventional Radiology · 2026
18. Pediatric Skin Cancer: Melanoma, Basal and Squamous Cell Carcinomas, and Dermatofibrosarcoma ProtuberansThe Journal of Dermatology · 2026
19. Impact of Treatment Response to Anticoagulant Therapy on Liver‐Related Events in Patients With Cirrhosis and Portal Vein ThrombosisHepatology Research · 2026
20. A Minimum 3‐Year Follow‐Up of Nivolumab‐Plus‐Ipilimumab in Japanese Patients With Advanced or Metastatic Renal Cell Carcinoma: A Final Analysis of the J‐ ENCORE StudyInternational Journal of Urology · 2026